Electra Therapeutics (ETRA) News
NASDAQ: ETRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ETRA news summary
We found 3 recent headlines mentioning Electra Therapeutics (ETRA): 0 in the past week and 2 in the past 30 days, most often from Seeking Alpha, GlobeNewswire, Nasdaq. ETRA is making an outsized move today, down 9.28% at $8.11, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Electra Therapeutics Q3 GAAP EPS of $3.47 beats by $4.44", was published by Seeking Alpha on Nov 13, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Electra Therapeutics headlines
- Electra Therapeutics Q3 GAAP EPS of $3.47 beats by $4.44Seeking Alpha
- Electra Therapeutics Reports Third Quarter 2026 Financial Results and Recent Portfolio HighlightsIpsoprubart Advancing in Global Registrational Program as Potential First Treatment for sHLH Broadly; Enrollment Completion Expected in Second Half of 2027GlobeNewswire
- JP Morgan Initiates Coverage of Electra Therapeutics at OverweightFintel reports that on October 22, 2026, JP Morgan initiated coverage of Electra Therapeutics (NASDAQGS:ETRA) with a Overweight recommendation. Prior to this rating action, the pre-action close for…Nasdaq